Symbol="ESPR"
AssetType="Common Stock"
Name="Esperion Therapeutics Inc"
Description="Esperion Therapeutics, Inc., a pharmaceutical company, develops and markets drugs for the treatment of patients with high low-density lipoprotein cholesterol in the United States and internationally. The company is headquartered in Ann Arbor, Michigan."
CIK="1434868"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="155329000"
EBITDA="-169470000"
PERatio="None"
PEGRatio="-4.78"
BookValue="-3.688"
DividendPerShare="0"
DividendYield="0"
EPS="-3.23"
RevenuePerShareTTM="1.068"
ProfitMargin="-2.528"
OperatingMarginTTM="-1.931"
ReturnOnAssetsTTM="-0.394"
ReturnOnEquityTTM="-2.608"
RevenueTTM="87913000"
GrossProfitTTM="-70419000"
DilutedEPSTTM="-3.23"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.369"
AnalystTargetPrice="10.28"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="5.98"
PriceToBookRatio="98.42"
EVToRevenue="6.93"
EVToEBITDA="-2.675"
Beta="0.154"
num_52WeekHigh="8.87"
num_52WeekLow="1.12"
num_50DayMovingAverage="1.456"
num_200DayMovingAverage="4.09"
SharesOutstanding="94713000"
DividendDate="None"
ExDividendDate="None"
symbol="ESPR"
open="1.65"
high="1.72"
low="1.62"
price="1.63"
volume="2823703.00"
latest_trading_day="2023-08-04"
previous_close="1.64"
change="-0.01"
change_percent="-0.6098%"
aroon_positive_momentum_days="25"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="25"
Volume_recent_avg="3495572"
Change_recent_avg="-0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.65"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="25"
Aroon_momentum_negative="75"
image_negative_thumbnail_id_1="1110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_negative_thumbnail_id_2="161"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_neutral_thumbnail_id_1="560"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="623"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_positive_thumbnail_id_2="678"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0030.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
